Literature DB >> 8990166

The motor domain and the regulatory domain of myosin solely dictate enzymatic activity and phosphorylation-dependent regulation, respectively.

M Sata1, W F Stafford, K Mabuchi, M Ikebe.   

Abstract

While the structures of skeletal and smooth muscle myosins are homologous, they differ functionally from each other in several respects, i.e., motor activities and regulation. To investigate the molecular basis for these differences, we have produced a skeletal/smooth chimeric myosin molecule and analyzed the motor activities and regulation of this myosin. The produced chimeric myosin is composed of the globular motor domain of skeletal muscle myosin (Met1-Gly773) and the C-terminal long alpha-helix domain of myosin subfragment 1 as well as myosin subfragment 2 (Gly773-Ser1104) and light chains of smooth muscle myosin. Both the actin-activated ATPase activity and the actin-translocating activity of the chimeric myosin were completely regulated by light chain phosphorylation. On the other hand, the maximum actin-activated ATPase activity of the chimeric myosin was the same as skeletal myosin and thus much higher than smooth myosin. These results show that the C-terminal light chain-associated domain of myosin head solely confers regulation by light chain phosphorylation, whereas the motor domain determines the rate of ATP hydrolysis. This is the first report, to our knowledge, that directly determines the function of the two structurally separated domains in myosin head.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 8990166      PMCID: PMC19241          DOI: 10.1073/pnas.94.1.91

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  42 in total

1.  Conformational states of smooth muscle myosin. Effects of light chain phosphorylation and ionic strength.

Authors:  K M Trybus; S Lowey
Journal:  J Biol Chem       Date:  1984-07-10       Impact factor: 5.157

2.  Charge replacement near the phosphorylatable serine of the myosin regulatory light chain mimics aspects of phosphorylation.

Authors:  H L Sweeney; Z Yang; G Zhi; J T Stull; K M Trybus
Journal:  Proc Natl Acad Sci U S A       Date:  1994-02-15       Impact factor: 11.205

3.  Enzymatic activities correlate with chimaeric substitutions at the actin-binding face of myosin.

Authors:  T Q Uyeda; K M Ruppel; J A Spudich
Journal:  Nature       Date:  1994-04-07       Impact factor: 49.962

4.  Regulation of expressed truncated smooth muscle myosins. Role of the essential light chain and tail length.

Authors:  K M Trybus
Journal:  J Biol Chem       Date:  1994-08-19       Impact factor: 5.157

5.  Preparation of myosin and its subfragments from rabbit skeletal muscle.

Authors:  S S Margossian; S Lowey
Journal:  Methods Enzymol       Date:  1982       Impact factor: 1.600

6.  Smooth muscle myosin light chain kinase.

Authors:  M P Walsh; S Hinkins; R Dabrowska; D J Hartshorne
Journal:  Methods Enzymol       Date:  1983       Impact factor: 1.600

7.  Light-chain phosphorylation controls the conformation of vertebrate non-muscle and smooth muscle myosin molecules.

Authors:  R Craig; R Smith; J Kendrick-Jones
Journal:  Nature       Date:  1983 Mar 31-Apr 6       Impact factor: 49.962

8.  Electron microscopic studies of myosin molecules from chicken gizzard muscle I: the formation of the intramolecular loop in the myosin tail.

Authors:  H Onishi; T Wakabayashi
Journal:  J Biochem       Date:  1982-09       Impact factor: 3.387

9.  Correlation of enzymatic properties and conformation of smooth muscle myosin.

Authors:  M Ikebe; S Hinkins; D J Hartshorne
Journal:  Biochemistry       Date:  1983-09-13       Impact factor: 3.162

10.  Antibodies probe for folded monomeric myosin in relaxed and contracted smooth muscle.

Authors:  A Horowitz; K M Trybus; D S Bowman; F S Fay
Journal:  J Cell Biol       Date:  1994-09       Impact factor: 10.539

View more
  4 in total

1.  Usher syndrome in Denmark: mutation spectrum and some clinical observations.

Authors:  Shzeena Dad; Nanna Dahl Rendtorff; Lisbeth Tranebjærg; Karen Grønskov; Helena Gásdal Karstensen; Vigdis Brox; Øivind Nilssen; Anne-Françoise Roux; Thomas Rosenberg; Hanne Jensen; Lisbeth Birk Møller
Journal:  Mol Genet Genomic Med       Date:  2016-06-28       Impact factor: 2.183

Review 2.  Linking the Landscape of MYH9-Related Diseases to the Molecular Mechanisms that Control Non-Muscle Myosin II-A Function in Cells.

Authors:  Gloria Asensio-Juárez; Clara Llorente-González; Miguel Vicente-Manzanares
Journal:  Cells       Date:  2020-06-12       Impact factor: 6.600

Review 3.  The Role of the L-Type Ca2+ Channel in Altered Metabolic Activity in a Murine Model of Hypertrophic Cardiomyopathy.

Authors:  Helena M Viola; Victoria P A Johnstone; Henrietta Cserne Szappanos; Tara R Richman; Tatiana Tsoutsman; Aleksandra Filipovska; Christopher Semsarian; Jonathan G Seidman; Christine E Seidman; Livia C Hool
Journal:  JACC Basic Transl Sci       Date:  2016-02-13

Review 4.  The Central Role of the F-Actin Surface in Myosin Force Generation.

Authors:  Matthew H Doran; William Lehman
Journal:  Biology (Basel)       Date:  2021-11-23
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.